Item 8.01. Other Events.
On January 25, 2022, HCM Acquisition Corp (the "Company") consummated its
initial public offering (the "IPO") of 28,750,000 units, including 3,750,000
units issued pursuant to the full exercise of the underwriter of its
over-allotment option (the "Units"). Each Unit consists of one Class A ordinary
share of the Company, par value $0.0001 per share ("Class A Ordinary Shares"),
and one-half of one redeemable warrant of the Company ("Warrant"), with each
whole Warrant entitling the holder thereof to purchase one Class A Ordinary
Share for $11.50 per share. The Units were sold at a price of $10.00 per Unit.
On January 25, 2022, simultaneously with the consummation of the IPO, the
Company completed the private sale (the "Private Placement") of an aggregate of
13,000,000 warrants (the "Private Placement Warrants") to HCM Investor Holdings,
LLC (the "Sponsor") and Cantor Fitzgerald & Co. at a purchase price of $1.00 per
Private Placement Warrant, generating gross proceeds to the Company of
$13,000,000.
A total of $293,250,000 of the proceeds from the IPO, comprised of $285,000,000
of the proceeds from the IPO (which amount includes $15,125,000 of the
underwriters' deferred discount) and $8,250,000 of the proceeds from the sale of
the Private Placement Warrants, was placed in a U.S.-based trust account at J.P.
Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust
Company, acting as trustee.
An audited balance sheet as of January 25, 2022 reflecting receipt of the
proceeds from the IPO and the Private Placement has been issued by the Company
and is included as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Audited Balance Sheet as of January 25, 2022.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
HCM ACQU 